D. Warner et al., Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography, THROMB HAEM, 85(3), 2001, pp. 408-411
Possession of the coagulation factor XIII Val34Leu (FXIIIVal34Leu) polymorp
hism is associated with protection against myocardial infarction (MI) in Ca
ucasians, in the absence of features of insulin resistance. The role of thi
s polymorphism in the UK Asian population, with its high prevalence of insu
lin resistance and ischaemic heart disease, is unknown. We investigated the
frequency of genotypes at this polymorphism, and measures of circulating F
XIII in a group of UK Asians attending for coronary angiography. Genotype a
t the FXIIIVal34Leu polymorphism was not associated with MI. FXIII B-subuni
t levels correlated with waist: hip ratio (r = 0.19, p <0.005), HbAlc (r =
0.18, p <0.05), fasting triglycerides (r = 0.21, p <0.005), total cholester
ol (r = 0.29, p <0.0005) and PAI-1 antigen (r = 0.24, p <0.005). An associa
tion between FXIIIVal34Leu and FXIII cross-linking activity was confirmed i
n these subjects tone-way ANOVA p <0.0005). This evidence does not support
the hypothesis that FXIIIVal34Leu is protective against MI in the UK Asian
population. FXIII B-subunit levels are strongly linked to risk factors for
cardiovascular disease, suggesting an underlying association with insulin r
esistance.